The role of CD52 cells in the allogeneic mixed lymphocyte reaction. (A)... | Download Scientific Diagram
Anti-CD52 (Epididymis-Specific Protein 5) Recombinant Rabbit Antibody
Neutrophils express CD52 and exhibit complement-mediated lysis in the presence of alemtuzumab - ScienceDirect
Anti‐CD52 antibody treatment in murine experimental autoimmune encephalomyelitis induces dynamic and differential modulation of innate immune cells in peripheral immune and central nervous systems - Barbour - 2022 - Immunology - Wiley Online Library
Anti Human CD52 Antibody, clone YTH34.5 | Bio-Rad
CD52 Gene - GeneCards | CD52 Protein | CD52 Antibody
High expression of CD52 in adipocytes: a potential therapeutic target for obesity with type 2 diabetes | Aging
Impacts on T cells via membrane CD52 and soluble CD52. Costimulation of... | Download Scientific Diagram
The therapeutic effect of anti-CD52 treatment in murine experimental autoimmune encephalomyelitis is associated with altered IL-33 and ST2 expression levels - ScienceDirect
Immune regulation by CD52-expressing CD4 T cells | Cellular & Molecular Immunology
Frontiers | CD52 Is a Prognostic Biomarker and Associated With Tumor Microenvironment in Breast Cancer
Strategies to improve allogeneic CAR T cells. (A) Elimination of the... | Download Scientific Diagram
Regulation unmasked by activation | Nature Immunology
CD52 Antibody (HI186) - BSA Free (NB500-311): Novus Biologicals
Frontiers | CD52 Is a Prognostic Biomarker and Associated With Tumor Microenvironment in Breast Cancer
CD52 as a molecular target for immunotherapy to treat acute myeloid leukemia with high EVI1 expression | Leukemia
Frontiers | CD52 Is Elevated on B cells of SLE Patients and Regulates B Cell Function
Functional and antitumor properties of TCR/CD52-de fi cient T cells... | Download Scientific Diagram
Human CD52 (Research Grade Alemtuzumab Biosimilar) Antibody MAB9889-100: R&D Systems
Immune regulation by CD52-expressing CD4 T cells | Cellular & Molecular Immunology
Human Peripheral Blood Mononuclear Cells Exhibit Heterogeneous CD52 Expression Levels and Show Differential Sensitivity to Alemtuzumab Mediated Cytolysis | PLOS ONE